This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Tumor necrosis factor receptor
From Proteopedia
(Difference between revisions)
| Line 65: | Line 65: | ||
**[[1aly]] – hTNFSF-5 extracellular domain <BR /> | **[[1aly]] – hTNFSF-5 extracellular domain <BR /> | ||
| - | **[[1i9r]] – hTNFSF-5 extracellular domain + antibody<BR /> | + | **[[1i9r]], [[5dmi]], [[5dmj]], [[5ihl]] – hTNFSF-5 extracellular domain + antibody<BR /> |
**[[3lkj]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | **[[3lkj]] – hTNFSF-5 extracellular domain + inhibitor<BR /> | ||
**[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | **[[3qd6]] – hTNFRSF-5 extracellular domain + CD40 ligand<br /> | ||
| Line 80: | Line 80: | ||
**[[4msv]] – hTNFRSF-6B extracellular domain + hTNFRSF-6 extracellular domain<br /> | **[[4msv]] – hTNFRSF-6B extracellular domain + hTNFRSF-6 extracellular domain<br /> | ||
**[[4kgg]], [[4kgq]], [[4j6g]] – hTNFRSF-6B extracellular domain + hTNFRSF-14 extracellular domain<br /> | **[[4kgg]], [[4kgq]], [[4j6g]] – hTNFRSF-6B extracellular domain + hTNFRSF-14 extracellular domain<br /> | ||
| - | **[[3mi8]] – hTNFRSF-6B extracellular domain + hTNFRSF-15 extracellular domain<br /> | + | **[[3mi8]], [[3k51]] – hTNFRSF-6B extracellular domain + hTNFRSF-15 extracellular domain<br /> |
| - | **[[ | + | **[[5l36]] – hTNFRSF-6B extracellular domain + hTNF ligand SF-6 extracellular domain<br /> |
| + | |||
| + | *Tumor necrosis factor receptor superfamily-9 (4-1BBL) | ||
| + | |||
| + | **[[2x29]] – hTNFSF-9 extracellular domain (mutant)<BR /> | ||
*Tumor necrosis factor receptor superfamily-10B (Dr5) | *Tumor necrosis factor receptor superfamily-10B (Dr5) | ||
| - | **[[2h9g]], [[4od2]], [[1za3]] – hTNFRSF-10B extracellular domain + antibody<br /> | + | **[[2h9g]], [[4od2]], [[1za3]], [[3x3f]] – hTNFRSF-10B extracellular domain + antibody<br /> |
**[[1d0g]] – hTNFRSF-10B extracellular domain + apoptosis-2 ligand<br /> | **[[1d0g]] – hTNFRSF-10B extracellular domain + apoptosis-2 ligand<br /> | ||
**[[1d4v]] – hTNFRSF-10B extracellular domain + TNF-related apoptosis inducing ligand<br /> | **[[1d4v]] – hTNFRSF-10B extracellular domain + TNF-related apoptosis inducing ligand<br /> | ||
**[[4i9x]] – hTNFRSF-10B extracellular domain + UL141<br /> | **[[4i9x]] – hTNFRSF-10B extracellular domain + UL141<br /> | ||
**[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | **[[4n90]] – hTNFRSF-10B + hTNFRSF-10 + antibody <br /> | ||
| - | |||
| - | *Tumor necrosis factor receptor superfamily-9 (4-1BBL) | ||
| - | |||
| - | **[[2x29]] – hTNFSF-9 extracellular domain (mutant)<BR /> | ||
*Tumor necrosis factor receptor superfamily-11 (RANKL) | *Tumor necrosis factor receptor superfamily-11 (RANKL) | ||
| Line 105: | Line 105: | ||
**[[3me4]] – mTNFRSF-11A extracellular domain <br /> | **[[3me4]] – mTNFRSF-11A extracellular domain <br /> | ||
| + | **[[5bnq]] – mTNFRSF-11A extracellular domain + TNF ligand SF-11<br /> | ||
*Tumor necrosis factor receptor superfamily-11B (Osteoprotegerin) | *Tumor necrosis factor receptor superfamily-11B (Osteoprotegerin) | ||
| Line 152: | Line 153: | ||
**[[4f42]], [[4f44]] – hTNFRSF-16 death domain<br /> | **[[4f42]], [[4f44]] – hTNFRSF-16 death domain<br /> | ||
| + | **[[2n97]] – hTNFRSF-16 death domain - NMR<br /> | ||
**[[1sg1]], [[3ij2]] – hTNFRSF-16 + beta nerve growth factor<br /> | **[[1sg1]], [[3ij2]] – hTNFRSF-16 + beta nerve growth factor<br /> | ||
**[[3buk]] – hTNFRSF-16 + neurotrophin-3<br /> | **[[3buk]] – hTNFRSF-16 + neurotrophin-3<br /> | ||
| + | **[[2n80]] – hTNFRSF-16 death domain + rho GDP-dissociation inhibitor - NMR<br /> | ||
| + | **[[2n83]] – hTNFRSF-16 death domain + receptor interacting Ser/Thr protein kinase - NMR<br /> | ||
*Tumor necrosis factor receptor superfamily-17 | *Tumor necrosis factor receptor superfamily-17 | ||
Revision as of 10:15, 28 September 2016
| |||||||||||
3D structures of tumor necrosis factor receptor
Updated on 28-September-2016
References
- ↑ Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol. 1999;17:331-67. PMID:10358762 doi:http://dx.doi.org/10.1146/annurev.immunol.17.1.331
- ↑ Lopalco G, Rigante D, Vitale A, Frediani B, Iannone F, Cantarini L. Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate. Clin Rheumatol. 2015 Apr;34(4):807-9. doi: 10.1007/s10067-014-2556-8. Epub 2014, Mar 11. PMID:24609716 doi:http://dx.doi.org/10.1007/s10067-014-2556-8
- ↑ Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996 Nov 15;4(11):1251-62. PMID:8939750
